Alpha 2.0
Login Register
» Authors » Darya Zharikova

Darya Zharikova

Explore the profile of Darya Zharikova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 329
Followers 0
Related Specialties
Microbiology
Molecular Biology
Infectious Diseases
Top 10 Co-Authors
Walter Gerhard
Krystyna Mozdzanowska
Jingqi Feng
Manxin Zhang
Laszlo Otvos
William Wunner
Henry Hoff
Mark Eid
Mare Cudic
Robert B Couch
Published In
J Virol
Virol J
Virology
Mol Immunol
Emerg Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse
Mozdzanowska K, Zharikova D, Cudic M, Otvos L, Gerhard W
Virol J . 2007 Nov; 4:118. PMID: 17974006
Background: The M2 ectodomain (M2e) of influenza A virus (IAV) strains that have circulated in humans during the past 90 years shows remarkably little structural diversity. Since M2e-specific antibodies (Abs)...
2.
Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2
Feng J, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, et al.
Virol J . 2006 Dec; 3:102. PMID: 17150104
Background: Matrix protein 2 (M2) is an integral tetrameric membrane protein of influenza A virus (IAV). Its ectodomain (M2e) shows remarkably little diversity amongst human IAV strains. As M2e-specific antibodies...
3.
Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components
Mozdzanowska K, Feng J, Eid M, Zharikova D, Gerhard W
Virology . 2006 Jun; 352(2):418-26. PMID: 16777168
The role of serum components in enhancing virus neutralizing (VN) activity of influenza virus A/PR/8/34 hemagglutinin (HA)-specific MAbs in vitro was investigated. The degree of enhancement depended on the MAb's...
4.
Prospects for universal influenza virus vaccine
Gerhard W, Mozdzanowska K, Zharikova D
Emerg Infect Dis . 2006 May; 12(4):569-74. PMID: 16704803
The current vaccination strategy against influenza A and B viruses is vulnerable to the unanticipated emergence of epidemic strains that are poorly matched by the vaccine. A vaccine that is...
5.
Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus
Zhang M, Zharikova D, Mozdzanowska K, Otvos L, Gerhard W
Mol Immunol . 2006 Feb; 43(14):2195-206. PMID: 16472860
The ectodomain of matrix protein 2 (M2e) has remained remarkably conserved amongst human influenza A viruses and is a target for Abs with protective activity. For these reasons, M2e is...
6.
Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2
Zharikova D, Mozdzanowska K, Feng J, Zhang M, Gerhard W
J Virol . 2005 May; 79(11):6644-54. PMID: 15890902
The ectodomain of matrix protein 2 (M2e) of human influenza type A virus strains has remained remarkably conserved since 1918. Because M2e-specific immunity has been shown to decrease morbidity and...
7.
Roles of CD4+ T-cell-independent and -dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies
Mozdzanowska K, Furchner M, Zharikova D, Feng J, Gerhard W
J Virol . 2005 Apr; 79(10):5943-51. PMID: 15857980
Previous studies have indicated that B cells make a significant contribution to the resolution of influenza virus infection. To determine how B cells participate in the control of the infection,...